Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations (Q34598512)

From Wikidata

Jump to navigation Jump to search

scholarly article

Language	Label	Description	Also known as
English	Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations	scholarly article

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

0 references

latent tuberculosis

1 reference

based on heuristic

inferred from title

0 references

Rochelle P. Walensky

3

1 reference

Europe PubMed Central

3 August 2017

2

object named as

Marc Lipsitch

0 references

object named as

Ted Cohen

1

0 references

author name string

Megan Murray

4

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

21 April 2006

1 reference

Europe PubMed Central

3 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

3 August 2017

103

1 reference

Europe PubMed Central

3 August 2017

18

1 reference

Europe PubMed Central

3 August 2017

7042-7047

1 reference

Europe PubMed Central

3 August 2017

Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Tuberculosis control in the era of HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

A re-examination of the potential impact of preventive therapy on the public health problem of tuberculosis in contemporary sub-Saharan Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Treatment of latent tuberculosis infection in HIV infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Tuberculosis epidemics driven by HIV: is prevention better than cure?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

The effect of drug resistance on the fitness of Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Antimicrobial use and antimicrobial resistance: a population perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Criteria for the control of drug-resistant tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Modeling the impact of global tuberculosis control strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Control strategies for tuberculosis epidemics: new models for old problems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Modelling the efficacy of prophylactic and curative therapies for preventing the spread of tuberculosis in Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

The intrinsic transmission dynamics of tuberculosis epidemics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Controlled chemoprophylaxis trials in tuberculosis. A general review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Potential of community-wide chemotherapy or immunotherapy to control the spread of HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Modeling zidovudine therapy: a cost-effectiveness analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Patients with active tuberculosis often have different strains in the same sputum specimen

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Understanding, predicting and controlling the emergence of drug-resistant tuberculosis: a theoretical framework

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Effect of drug resistance on the generation of secondary cases of tuberculosis

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Does DOTS work in populations with drug-resistant tuberculosis?

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Early therapy for latent tuberculosis infection.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

The reinfection threshold promotes variability in tuberculosis epidemiology and vaccine efficacy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

26 October 2018

Will tuberculosis become resistant to all antibiotics?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

26 October 2018

Exogenous reinfection in tuberculosis

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

In Vivo Phenotypic Dominance in Mouse Mixed Infections withMycobacterium tuberculosisClinical Isolates

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Evaluation of tuberculosis control policies using computer simulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16632605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.0600349103

1 reference

Europe PubMed Central

3 August 2017

2006PNAS..103.7042C

0 references

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34598512&oldid=1647502157"